Pittsburgh, PA7 Active Studies

Traumatic Brain Injury Clinical Trials in Pittsburgh, PA

Find 7 actively recruiting traumatic brain injury clinical trials in Pittsburgh, PA. Connect with local research sites and explore new treatment options.

7
Active Trials
6
Sponsors
3,150
Enrolling

Recruiting Traumatic Brain Injury Studies in Pittsburgh

About Traumatic Brain Injury Clinical Trials in Pittsburgh

Traumatic brain injury (TBI) results from a violent blow or jolt to the head or body that disrupts normal brain function. Effects can range from mild concussions to severe cognitive impairment. Treatment depends on severity and may include rehabilitation, medication, and surgery.

There are currently 7 traumatic brain injury clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 3,150 participants. Research is being sponsored by Hoffmann-La Roche, Shawn Eagle, David Okonkwo, MD, PhD and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Traumatic Brain Injury Clinical Trials in Pittsburgh — FAQ

Are there traumatic brain injury clinical trials in Pittsburgh?

Yes, there are 7 traumatic brain injury clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What traumatic brain injury treatments are being tested?

The 7 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for traumatic brain injury.

Data updated July 17, 2026 from ClinicalTrials.gov